Europe Against Cancer | GenomeWeb

Europe Against Cancer

The group from Imperial College London's Hammersmith Hospital has developed a duplex qPCR assay that measures both BCR-ABL1 target and endogenous control transcripts in the same reaction with no loss of sensitivity compared to a previously used simplex test.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.